Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Más filtros











Base de datos
Tipo de estudio
Intervalo de año de publicación
4.
Ann Pharmacother ; 48(10): 1376-9, 2014 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-24994724

RESUMEN

OBJECTIVE: To report successful use of low-volume intrathecal (IT) daptomycin and loading strategy for the treatment of ventriculostomy-associated meningitis. CASE SUMMARY: A 23-year-old man with a history of multiple ventriculoperitoneal shunt revisions resulting from multidrug-resistant Staphylococcus epidermidis shunt infection presented with meningitis despite suppressive antibiotic therapy. After source control surgery, the patient improved with intravenous daptomycin plus IT vancomycin. Then, 4 days later, significant ventriculostomy output occurred, and the S epidermidis was confirmed to be intermediately sensitive to vancomycin (MIC = 8 µg/mL) and susceptible to daptomycin (MIC = 2 µg/mL). IT vancomycin was changed to IT daptomycin 5 mg in 3 mL normal saline (NS) every 24 hours for 3 days, then every 72 hours for 18 days. The cerebrospinal fluid (CSF) was sterile after 1 day of IT daptomycin and remained so. Creatine kinase remained normal throughout the course of treatment. The patient was discharged on hospital day 50 without antibiotics. DISCUSSION: IT daptomycin has been reported for adult doses ranging from 5 to 10 mg once every 24 to 72 hours in volumes ranging from 5 to 10 mL; drug accumulation has been seen after the third dose of once every 24 hours dosing, and delayed improvement has been seen with once every 72 hours dosing. We planned for rapid load and CSF sterilization and extended the dosing interval once drug accumulation was expected to have occurred. CONCLUSIONS: IT daptomycin 5 mg diluted to 3 mL in NS and dosed in a loading strategy was effective and without adverse sequelae.


Asunto(s)
Antibacterianos/uso terapéutico , Daptomicina/uso terapéutico , Meningitis Bacterianas/tratamiento farmacológico , Infecciones Estafilocócicas/tratamiento farmacológico , Staphylococcus epidermidis/efectos de los fármacos , Adulto , Coagulasa/metabolismo , Farmacorresistencia Bacteriana Múltiple , Humanos , Infusión Espinal , Masculino , Meningitis Bacterianas/microbiología , Infecciones Estafilocócicas/microbiología , Staphylococcus epidermidis/enzimología , Vancomicina/uso terapéutico , Ventriculostomía/efectos adversos
6.
Mol Cell Neurosci ; 28(2): 215-28, 2005 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-15691704

RESUMEN

Rap1 is a small GTP-binding protein that has been implicated in intracellular signaling and cytoskeletal control. Here, we show that Rap1 is expressed in rat cortical neurons and plays a critical role in dendritic development. Inhibition of Rap1 signaling either by expressing dominant negative mutant of Rap1 or Rap1GAP in cortical neurons reduced dendritic complexity. In contrast, expression of a constitutively active mutant of Rap1 (Rap1V12) induced dendritic growth and branching. Membrane depolarization, which induces dendritic growth via calcium influx, led to a rapid activation of Rap1 via cAMP and cGMP signaling. A CREB-dependent mechanism is involved in depolarization-induced dendritic growth in cortical neurons. Rap1 function contributed to depolarization induced CREB activation, and inhibition of CREB suppressed dendritic growth induced by Rap1V12. These observations identify Rap1 as a key mediator of calcium regulation of CREB-dependent transcription and dendritic development.


Asunto(s)
Diferenciación Celular/genética , Corteza Cerebral/embriología , Corteza Cerebral/crecimiento & desarrollo , Dendritas/fisiología , Regulación del Desarrollo de la Expresión Génica/genética , Proteínas de Unión al GTP rap1/metabolismo , Animales , Animales Recién Nacidos , Canales de Calcio/metabolismo , Señalización del Calcio/fisiología , Células Cultivadas , Corteza Cerebral/citología , AMP Cíclico/metabolismo , Proteína de Unión a Elemento de Respuesta al AMP Cíclico/metabolismo , GMP Cíclico/metabolismo , Dendritas/metabolismo , Dendritas/ultraestructura , Potenciales de la Membrana/fisiología , Proteína Quinasa 3 Activada por Mitógenos/metabolismo , Mutación/genética , Ratas , Ratas Long-Evans , Receptores de N-Metil-D-Aspartato/metabolismo , Sistemas de Mensajero Secundario/fisiología , Transducción de Señal/genética , Proteínas de Unión al GTP rap1/genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA